Effect of remdesivir on mortality in patients with COVID‐19: A meta‐analysis of randomized control trials
Open Access
- 29 October 2020
- journal article
- letter
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (4) , 1860-1861
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19New England Journal of Medicine, 2020
- Remdesivir for the Treatment of Covid-19 — Final ReportNew England Journal of Medicine, 2020
- Effectiveness of remdesivir for the treatment of hospitalized COVID‐19 persons: A network meta‐analysisJournal of Medical Virology, 2020
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialThe Lancet, 2020